These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36135777)

  • 21. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count.
    Lacou M; Leroy M; Le Lan N; Toquet C; Espitia-Thibault A; Graveleau J; Masseau A; Agard C; Volteau C; Mussini JM; Hamidou M; Néel A
    Rheumatology (Oxford); 2021 Feb; 60(2):699-707. PubMed ID: 32789447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
    Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.
    Van Gool IC; Kers J; Bakker JA; Rotmans JI; Teng YKO; Bauer MP
    Clin Rheumatol; 2022 Oct; 41(10):2949-2960. PubMed ID: 35732985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung biopsy in the diagnosis of pediatric ANCA-associated vasculitis.
    Sayad E; Vogel TP; Cortes-Santiago N; Patel KR; McNeill DM; Spielberg D; Silva-Carmona M
    Pediatr Pulmonol; 2021 Jan; 56(1):145-152. PubMed ID: 33146463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection-induced myeloperoxidase specific antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis: A systematic review.
    Kakoullis L; Parperis K; Papachristodoulou E; Panos G
    Clin Immunol; 2020 Nov; 220():108595. PubMed ID: 32961330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 Patients.
    Lhote R; Chilles M; Groh M; Puéchal X; Guilpain P; Ackermann F; Amoura Z; Annesi-Maesano I; Barba T; Catherinot E; Cohen-Aubart F; Cohen P; Cottin V; Couderc LJ; De Boysson H; Delbrel X; Dominique S; Duhaut P; Fain O; Hachulla E; Hamidou M; Kahn JE; Legendre C; Le Quellec A; Lhote F; Lifermann F; Mathian A; Néel A; Nunes H; Subra JF; Terrier B; Mouthon L; Diot E; Guillevin L; Brillet PY; Tcherakian C;
    J Rheumatol; 2020 Oct; 47(10):1522-1531. PubMed ID: 31787599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications and diagnostic outcome of antineutrophil cytoplasmic antibody testing in hospital medicine: a pattern of over-screening.
    Xu Y; Khamis N; Khosravi-Hafshejani T; Tan J; Miles E; Avina-Zubieta JA; Shojania K; Nimmo M; Dehghan N
    Clin Rheumatol; 2021 Dec; 40(12):4983-4991. PubMed ID: 34342740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis.
    Choi H; Park YB; Song J; Lee SW
    Z Rheumatol; 2022 Oct; 81(8):705-711. PubMed ID: 33904985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical Reactivation of Cytomegalovirus Drives CD4+CD28null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Chanouzas D; Sagmeister M; Faustini S; Nightingale P; Richter A; Ferro CJ; Morgan MD; Moss P; Harper L
    J Infect Dis; 2019 Jan; 219(2):234-244. PubMed ID: 30102389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study.
    Santos RP; Dos Reis-Neto ET; Pinheiro MM
    Adv Rheumatol; 2019 May; 59(1):18. PubMed ID: 31088558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 33. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review.
    Choi CB; Park YB; Lee SW
    Yonsei Med J; 2019 Jan; 60(1):10-21. PubMed ID: 30554486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infection in ANCA-associated vasculitis: Between the Devil and Deep blue sea. Case series and review of the literature.
    Baliga S; Yadav S; Sagdeo P; Balakrishnan C
    Clin Rheumatol; 2024 Feb; 43(2):785-797. PubMed ID: 37798405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with seven Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with remission-induction therapy with intravenous cyclophosphamide according to the CYCLOPS protocol.
    Oiwa H; Yamasaki S; Endo K; Nojima T; Kumagai K; Sugiyama E
    Intern Med; 2014; 53(20):2291-6. PubMed ID: 25318790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
    Palsson R; Choi HK; Niles JL
    J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
    Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.